In a concerning development, NAFDAC of Nigeria has issued a recall of a batch of Johnson & Johnson brand children’s cough syrup due to alarming reasons.
The primary cause for this recall is the presence of a toxic substance. Laboratory tests uncovered an unacceptable level of diethylene glycol, a potentially fatal toxic compound. The existence of diethylene glycol in this syrup poses a significant health risk, especially to children. The toxic effects of this substance include symptoms such as abdominal pain, vomiting, diarrhea, inability to urinate, headache, mental disturbances, and acute kidney injury, which can be fatal.
Furthermore, NAFDAC emphasized that this particular batch of Benylin brand children’s syrup, identified by batch number 329304, fails to meet the required quality standards. Laboratory tests confirmed its non-compliant nature and acute oral toxicity.
This recall follows reports of recent adverse reactions and fatalities in children in Cameroon and The Gambia linked to the consumption of products containing diethylene glycol. Consequently, NAFDAC strongly advises against the importation, distribution, sale, or use of this contaminated product. Individuals in possession of the recalled product are urged to immediately cease its sale or use and return the stock to the nearest NAFDAC office.
In the event of adverse reactions, especially in children, it is crucial to promptly consult a doctor. Despite these alarming findings, Johnson & Johnson, the South Africa-based manufacturer, has yet to make a statement in response to NAFDAC’s announcement.
This case underscores the critical significance of monitoring the quality of pharmaceutical products and safeguarding consumers, particularly vulnerable populations such as children. Health authorities must remain vigilant to avert such risks to public health.
For more information on this topic, you can visit the following relevant articles: